4//SEC Filing
CEDARS SINAI MEDICAL CENTER 4
Accession 0001209191-21-021223
CIK 0001718852other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 9:53 PM ET
Size
23.1 KB
Accession
0001209191-21-021223
Insider Transaction Report
Form 4
CEDARS SINAI MEDICAL CENTER
10% Owner
Transactions
- Conversion
Common Stock
2021-03-16+361,566→ 5,008,508 total - Conversion
Series C Preferred Stock
2021-03-16−25,000,000→ 0 total→ Common Stock (2,500,000 underlying) - Conversion
Series D-2 Preferred Stock
2021-03-16−3,615,656→ 0 total→ Common Stock (361,566 underlying) - Conversion
Common Stock
2021-03-16+1,200,000→ 1,892,500 total - Conversion
Common Stock
2021-03-16+254,442→ 4,646,942 total - Conversion
Series A Preferred Stock
2021-03-16−1,000,000→ 0 total→ Common Stock (100,000 underlying) - Conversion
Series B Preferred Stock
2021-03-16−12,000,000→ 0 total→ Common Stock (1,200,000 underlying) - Conversion
Common Stock
2021-03-16+100,000→ 692,500 total - Conversion
Common Stock
2021-03-16+2,500,000→ 4,392,500 total - Conversion
Series D-1 Preferred Stock
2021-03-16−2,544,425→ 0 total→ Common Stock (254,442 underlying)
Footnotes (5)
- [F1]The shares of the Issuer's Series A Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering.
- [F2]The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering.
- [F3]The shares of the Issuer's Series C Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering.
- [F4]The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering.
- [F5]The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering.
Documents
Issuer
Prometheus Biosciences, Inc.
CIK 0001718852
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001269910
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 9:53 PM ET
- Size
- 23.1 KB